Flagship Pioneering’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $2.78M | Hold |
|
|||||
|
2024
Q2 | $6.68M | Hold |
|
|||||
|
2024
Q1 | $6.92M | Buy |
|
|||||
|
2023
Q4 | $10.1M | Buy |
|
|||||
|
2023
Q3 | $3.93M | Hold |
|
|||||
|
2023
Q2 | $3.13M | Hold |
|
|||||
|
2023
Q1 | $2.65M | Hold |
|
|||||
|
2022
Q4 | $3.57M | Hold |
|
|||||
|
2022
Q3 | $6.4M | Buy |
|
|||||
|
2022
Q2 | $2.82M | Hold |
|
|||||
|
2022
Q1 | $3.5M | Hold |
|
|||||
|
2021
Q4 | $9.58M | Hold |
|
|||||
|
2021
Q3 | $13.1M | Hold |
|
|||||
|
2021
Q2 | $16M | Hold |
|
|||||
|
2021
Q1 | $22M | Hold |
|
|||||
|
2020
Q4 | $31.9M | Hold |
|
|||||
|
2020
Q3 | $26M | Hold |
|
|||||
|
2020
Q2 | $31.3M | Hold |
|
|||||
|
2020
Q1 | $17.4M | Hold |
|
|||||
|
2019
Q4 | $20.3M | Hold |
|
|||||
|
2019
Q3 | $30.5M | Sell |
|
|||||
|
2019
Q2 | $29.7M | Hold |
|
|||||
|
2019
Q1 | $29.3M | Hold |
|
|||||
|
2018
Q4 | $17.8M | Hold |
|
|||||
|
2018
Q3 | $38.2M | Hold |
|
|||||
|
2018
Q2 | $32.7M | Hold |
|
|||||
|
2018
Q1 | $41.6M | Hold |
|
|||||
|
2017
Q4 | $31.2M | Hold |
|
|||||
|
2017
Q3 | $47.2M | Sell |
|
|||||
|
2017
Q2 | $77.3M | Hold |
|
|||||
|
2017
Q1 | $76.6M | Hold |
|
|||||
|
2016
Q4 | $58.4M | Hold |
|
|||||
|
2016
Q3 | $66.7M | Buy |
|